Catalyst Wire Dossier Catalyst Wire Dossier

ACE inhibitor + calcium channel blocker regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACE inhibitor + calcium channel blocker regimen, covering 2012-01-18 to 2012-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker [Phase 4]

See pricing